A major scientific advancement could reshape the fight against cancer. For the first time, researchers have created a detailed genetic map of cancers in domestic cats. By analyzing tumor DNA from nearly 500 felines, scientists identified mutations, several of which correspond to those observed in humans.
The findings, published on February 19 in the scientific journal Science, revealed a clear connection: the biological mechanisms driving certain tumors are, in part, shared between the two species. Until now, feline cancer genetics remained largely unknown.
“Feline cancer genetics was a complete mystery,” explained lead researcher Dr. Louise Van der Wayden, emphasizing that a better understanding of cancer, regardless of the species studied, benefits all medical research.
The study, led by the Wellcome Sanger Institute of Cambridge, focused on nearly 1,000 genes involved in thirteen types of feline cancers.
One finding particularly caught the scientists’ attention: triple-negative breast cancer. This aggressive form accounts for approximately 15% of breast cancers in women. It appears more frequently in cats, offering researchers expanded access to biological samples and potentially opening the door to identifying new therapeutic targets and developing innovative treatments.
Cancer ranks among the leading causes of disease and mortality in cats. Yet, unlike the numerous studies dedicated to canine cancers, research on feline cancers has been limited. This new genetic database represents a crucial step forward for veterinary medicine.
Scientists also highlight the environmental relevance of this work. Cats share our living spaces and are exposed to the same environmental factors, such as household pollution, diet, and chemicals.
A newly published genetic map of feline cancers is providing researchers with unprecedented insights into the disease, potentially accelerating the development of new treatments for both animals and humans. The study, published February 19 in Science, details the analysis of tumor DNA from nearly 500 cats, revealing shared genetic mutations with human cancers.
Researchers at the Wellcome Sanger Institute in Cambridge focused on nearly 1,000 genes linked to thirteen different types of feline cancer. The detailed genetic mapping, a first for domestic cats, could significantly improve veterinary care and contribute to broader cancer research. According to Dr. Louise Van der Wayden, the lead researcher, “Feline cancer genetics was a complete mystery,” but a better understanding of the disease across species benefits the entire field of medical research.
The study’s findings are particularly promising for understanding triple-negative breast cancer, an aggressive form of the disease that affects roughly 15% of women. This type of cancer appears to be more prevalent in cats, providing researchers with a larger pool of samples to study and potentially identify new therapeutic targets. The increased availability of biological samples could accelerate the development of innovative treatments.
Cancer is a major health concern for cats, and this research addresses a significant gap in veterinary oncology. While canine cancers have been extensively studied, feline cancers have received comparatively little attention. This new genetic database is expected to be a foundational resource for advancing veterinary medicine. The researchers also noted that cats, like humans, are exposed to similar environmental factors – including pollution, diet, and chemicals – making them a valuable model for studying the environmental influences on cancer development.
The findings from this study underscore the importance of comparative oncology, where research on animal cancers can provide valuable insights into human disease. This research could ultimately lead to more effective cancer treatments for both pets and people.
